Cancer Research Institute (CRI) shared a post on LinkedIn:
“Researchers including CRI Scientific Advisory Council member Dr. Nir Hacohen and former CRI Fellow Dr. Susan Klaeger of Broad Institute of MIT and Harvard recently published ‘promising results from a clinical trial testing the effectiveness of a new cancer vaccine that treats patients with kidney cancer,’ Yale Daily News describes.
‘The team’s vaccine represents a recent shift to more targeted cancer therapies than general treatments like surgery, radiation and chemotherapy that tend to prolong life in advanced cancer patients but do not usually elicit long-term responses.’
Explore.”
More posts featuring Cancer Research Institute.